mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.08 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.082 |
0.08 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.08 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.08 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.08 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.08 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
0.21 |
0.09 |